Trial intelligence / Profile preview

122-0551 in plaque psoriasis

NCT01700985Phase 2Completed

Start
May 2012
Primary completion
Sep 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of halobetasol in plaque psoriasis. Started May 2012; status: completed.

02

Drugs

halobetasol
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT01700985.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01700985.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call